Stemtech Financials
| STEK Stock | USD 0.05 0 2.80% |
With this module, you can analyze Stemtech financials for your investing period. You should be able to track the changes in Stemtech individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Stemtech |
The data published in Stemtech's official financial statements typically reflect Stemtech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Stemtech's quantitative information. For example, before you start analyzing numbers published by Stemtech accountants, it's essential to understand Stemtech's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Stemtech Stock Summary
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. Stemtech Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 10370 USA Today |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.stemtech.com |
| Phone | 954 715 6000 |
| Currency | USD - US Dollar |
Stemtech Key Financial Ratios
Stemtech's financial ratios allow both analysts and investors to convert raw data from Stemtech's financial statements into concise, actionable information that can be used to evaluate the performance of Stemtech over time and compare it to other companies across industries.Stemtech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stemtech's current stock value. Our valuation model uses many indicators to compare Stemtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stemtech competition to find correlations between indicators driving Stemtech's intrinsic value. More Info.Stemtech is rated fourth in return on asset category among its peers. It is rated second in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stemtech's earnings, one of the primary drivers of an investment's value.Stemtech Systematic Risk
Stemtech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Stemtech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Stemtech correlated with the market. If Beta is less than 0 Stemtech generally moves in the opposite direction as compared to the market. If Stemtech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Stemtech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Stemtech is generally in the same direction as the market. If Beta > 1 Stemtech moves generally in the same direction as, but more than the movement of the benchmark.
Stemtech December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Stemtech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stemtech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stemtech based on widely used predictive technical indicators. In general, we focus on analyzing Stemtech OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stemtech's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.09 | |||
| Information Ratio | 0.0774 | |||
| Maximum Drawdown | 128.14 | |||
| Value At Risk | (12.57) | |||
| Potential Upside | 9.3 |
Other Information on Investing in Stemtech OTC Stock
Stemtech financial ratios help investors to determine whether Stemtech OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemtech with respect to the benefits of owning Stemtech security.